NantKwest Stock News

Gilead Sciences, Inc. (Nasdaq: GILD), Kite, a Gilead Company, and oNKo-innate announced the companies have entered into a three-year cancer immunotherapy research collaboration to support discovery an

Dr. Patrick Soon-Shiong’s NantKwest Inc. and ImmunityBio Inc. are developing potential vaccines and therapeutics to combat COVID-19.

Shares of small-cap immunotherapy company Nantkwest Inc (NASDAQ: NK), a leading producer of clinical dose forms of off-the-shelf natural killer cell therapies, were adding to Monday's gains in Tuesday

Movers Indices • S&P 500 ETF (NYSE:SPY) rose 1.80% to $280.58.• Nasdaq ETF (NASDAQ:QQQ) rose 1.96% to $207.• Dow Jones Industrial Average ETF (NYSE:DIA) rose 1.75% to $238.27.• FTSE/Xinhua Chi

Sonnet BioTherapeutics Holdings (NASDAQ:SONN) +100%.MEI Pharma (NASDAQ:MEIP) +71% on license deal for blood cancer candidate.NantKwest (NASDAQ:NK) +39% being with ImmunityBio on active discussion

NantKwest, Inc. (NASDAQ: NK) and ImmunityBio, Inc., clinical-stage immunotherapy companies within the NantWorks family of companies, today announced they are in active discussions with the U.S. Food a

Shares of small-cap immunotherapy company Nantkwest Inc (NASDAQ: NK), a leading producer of clinical dose forms of off-the-shelf natural killer cell therapies, were adding to...

NantKwest, Inc. (Nasdaq: NK), a next-generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat cancer and in

Two Chinese nationals acting for North Korean used ‘peel chains’ and doctored KYC photos to help launder more than $100 million in stolen cryptocurrency.

Investors need to pay close attention to NantKwest (NK) stock based on the movements in the options market lately.

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 16.) Acceleron Pharma Inc (NASDAQ: XLRN ) A

Midway through trading Tuesday, the Dow traded up 0.38% to 29,018.33 while the NASDAQ rose 0.01% to 9,274.37. The S&P also rose, gaining 0.01% to 3,288.18. Leading and Lagging...

Following the market opening Tuesday, the Dow traded up 0.03% to 28915.99 while the NASDAQ fell 0.16% to 9259.39. The S&P also fell, dropping 0.16% to 3,283.01. Leading and...

Fluidigm sees Q4 revenue $32M-$32.4M, consensus $30.16M FLDM

ANI Pharmaceuticals launches Paliperidone Extended-Release Tablets ANIP